[1]张均平,刘会杰,杨洋,等.(R)-Roscovitine诱导Hela细胞凋亡的分子机制[J].华侨大学学报(自然科学版),2013,34(4):422-428.[doi:10.11830/ISSN.1000-5013.2013.04.0422]
　ZHANG Jun-ping,LIU Hui-jie,YANG Yang,et al.Caspase-Dependent and-Independent Pathways for (R)-Roscovitine-Induced Apoptosis in Hela Cells[J].Journal of Huaqiao University(Natural Science),2013,34(4):422-428.[doi:10.11830/ISSN.1000-5013.2013.04.0422]
点击复制

(R)-Roscovitine诱导Hela细胞凋亡的分子机制()
分享到：

《华侨大学学报（自然科学版）》[ISSN:1000-5013/CN:35-1079/N]

卷:
第34卷
期数:
2013年第4期
页码:
422-428
栏目:
出版日期:
2013-07-20

文章信息/Info

Title:
Caspase-Dependent and-Independent Pathways for (R)-Roscovitine-Induced Apoptosis in Hela Cells
文章编号:
1000-5013(2013)04-0422-07
作者:
张均平1; 2;  刘会杰1; 2;  杨洋1; 2;  许瑞安1; 2
1. 华侨大学 分子药物研究院, 福建 厦门 361021;2. 华侨大学 分子药物教育部工程研究中心, 福建 厦门 361021
Author(s):
ZHANG Jun-ping;  LIU Hui-jie;  YANG Yang;  XU Rui-an
1.Institute of Molecular Medicine, Huaqiao University, Xiamen 361021, China; 2.Engineering Research Center of Molecular Medicine, Ministry of Education, Huaqiao University, Xiamen 361021, China
关键词:
(R)-roscovitine;  细胞周期蛋白依赖性激酶;  细胞凋亡;  凋亡诱导因子;  半胱天冬酶
Keywords:
(R)-roscovitine;  cyclin-dependent kinases;  apoptosis;  apoptosis inducing factor;  caspase
分类号:
730.231;R735.2
DOI:
10.11830/ISSN.1000-5013.2013.04.0422
文献标志码:
A
摘要:
以Hela细胞为模型, 探讨细胞周期蛋白依赖性激酶抑制剂(R)-roscovitine对Hela细胞凋亡诱导的可能途径, 进一步了解其诱导肿瘤细胞凋亡的分子机制.结果显示:(R)-roscovitine明显抑制Hela细胞的增殖,在17.5~140.0 μmol·L-1浓度作用12,24,48 h后,Hela细胞的增殖抑制率分别为8.48%~33.76%,25.19%~86.41%和47.90%~88.08%;典型凋亡的DNA ladder被诱导,且凋亡率随药物浓度的增加而升高;经半胱天冬酶-3(caspase-3)特异性抑制剂Ac-DEVD-CHO或半胱天冬酶泛抑制剂Z-VAD-FMK处理后,(R)-roscovitine对Hela细胞凋亡的诱导被抑制约20%,说明半胱天冬酶依赖的途径参与了(R)-roscovitine对Hela细胞凋亡的诱导;(R)-roscovitine诱导凋亡诱导因子(AIF)从线粒体释放细胞核中,且Ac-DEVD-CHO和Z-VAD-FMK没有抑制AIF的释放,这意味着(R)-roscovitine能够诱导Hela细胞凋亡,其机制是通过caspase与非caspase依赖两种途径.
Abstract:
Hela cells used as a model, investigate that the cell apoptosis pathways induced by cyclin dependent kinase inhibitor(R)-roscovitine and further understand that molecular mechanism by which(R)-roscovitinee induced cell apoptosis. The results showed that the proliferation of Hela cells was significantly inhibited by(R)-roscovitine, the cell viability was reduced by 8.48%-33.76%, 25.19%-86.41% and 47.90%-88.08%, respectively, after treatment with(R)-roscovitine(17.5-140.0 μmol·L-1)for 12, 24 and 48 h.After treatment of Hela cell with(R)-roscovitine for 24 h, the obvious changes in cell morphology occurred by cell shrinkage, round and adherence decrease. Characteristic change of apoptosis with DNA ladder was induced and apoptosis increased with increasing concentration of(R)-roscovitine. Moreover, in the presence of caspase-3 special inhibitor Ac-DEVD-CHO or caspase-pan inhibitor Z-VAD-FMK, the(R)-roscovitine induced apoptosis was reduced by about 20%, suggesting that caspase dependent pathway particaipated in the apoptosis induced by(R)-roscovitine.(R)-roscovitine induced apoptosis inducing factor(AIF), which could release from mitochondria to nuclei, in the presence or absence of Z-VAD-FMK, demonstrating that(R)-roscovitine could induce apoptosis and its mechanism by which was through both caspase dependent and independent caspase pathways.

参考文献/References:

[1] RAYNAUD F I,WHITTAKER S R,FISCHER P M,et al.In vitro and in vivo pharmacokinetic-pharmacodynamic relationships for the trisubstituted aminopurine cyclin-dependent kinase inhibitors olomoucine,bohemine and CYC202[J].Clin Cancer Res,2005,11(13):4875-4887.
[2] DICKSON M A,SCHWARTZ G K.Development of cell-cycle inhibitors for cancer therapy[J].Curr Oncol,2009,16(2):36-43.
[3] ALDOSS I T,TASHI T,GANTI A K.Seliciclib in malignancies[J].Expert Opin Inv Drug,2009,18(12):1957-1965.
[4] MEIJER L.Chemical inhibitors of cyclin-dependent kinesis[J].Trends Cell Biol,1996,6(10):393-397.
[5] MGBONYEBI O P,RUSSO J,RUSSO I H.Roscovitine induces cell death and morphologicalchanges indicative of apoptosis in MDA-MB-231 breast cancer cells[J].Cancer Res,1999,59(8):1903-1910.
[6] ALVI A J,AUSTEN B,WESTON V J,et al.A novel CDK inhibitor,CYC202(R-roscovitine), overcomes the defect in p53-dependent apoptosis in B-CLL by down-regulation of genes involved in transcription regulation and survival[J].Blood,2005,105(11):4484-4491.
[7] APPLEYARD M V,O’NEILL M A,MURRAY K E,et al.Seliciclib(CYC202, R-roscovitine)enhances the antitumor effect of doxorubicin in vivo in a breast cancer xenograft model[J].Int J Cancer,2009,124(2):465-472.
[8] LJUNGMAN M,PAULSEN M T.The cyclin-dependent kinase inhibitor roscovitine inhibits RNA synthesis and triggers nuclear accumulation of p53 that is unmodified at Ser15 and Lys382[J].Mol Pharmacol,2001,60(4):785-789.
[9] 高建新,周玉琴,张茹华,等.Caspase-3在roscovitine诱发PC12细胞凋亡中发挥重要作用[J].生理学报,2005,57(6):755-760.
[10] 于翠娟,王成济,杨安钢.AIF及AIF依赖的凋亡[J].医学分子生物学杂志,2003,25(6):351-353.
[11] 赵文丽.细胞凋亡及其检测技术的进展[J].山西职工医学院学报,2004,14(2):68-69.
[12] CANDé C,CECCONI F,DESSEN P,et al.Apoptosis-inducing factor(AIF): Key to the conserved caspase-independent pathways of cell death?[J].J Cell Sci,2002,115(24):4727-4734.
[13] SUSIN S A,LORENZO H K,ZAMZAMI N,et al.Molecular characterization of mitoch-ondrial apoptosis-inducing factor[J].Nature,1999,397(6718):441-446.
[14] 陈默,潘敏慧,周恩昆,等.凋亡诱导因子的研究进展[J].细胞生物学杂志,2007,29(6):791-794.
[15] HUANG H,REGAN KM,LOU Z,et al.CDK2-dependent phosphorylation of FOXO1 as an apoptotic response to DNA damage[J].Science,2006,314(5797):294-297.

备注/Memo

备注/Memo:
收稿日期: 2013-01-23
通信作者: 许瑞安(1948-),男,教授,主要从事分子药物、分子医学、海洋与基因工程药物的研究.E-mail:ruianxu@hqu.edu.cn.
基金项目: 国家自然科学基金资助项目(81072578)
更新日期/Last Update: 2013-07-20